Name | [(2R,3R,4R,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] (E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate |
---|
Description | Leucosceptoside A is a phenylethanoid glycoside with anti-hyperglycemic and anti-hypertensive activities. Leucosceptoside A shows inhibitory activity against α-glucosidase and PKCα (IC50 of 19.0 μM)[1][2][3]. |
---|---|
Related Catalog | |
Target |
PKCα:19 μM (IC50) |
In Vitro | Leucosceptoside A shows weak angiotensin converting enzyme (ACE) inhibitory effect[1]. Leucosceptoside A (4-16 μM) significantly reduces 1-methyl-4-phenylpyridinium ion (MPP+)-induced death of mesencephalic neurons[2]. |
References |
Density | 1.545g/cm3 |
---|---|
Boiling Point | 884.547ºC at 760 mmHg |
Molecular Formula | C30H38O15 |
Molecular Weight | 638.61400 |
Flash Point | 283.993ºC |
Exact Mass | 638.22100 |
PSA | 234.29000 |
Index of Refraction | 1.664 |